Sun Pharma’s head of biologics marketing Maureen Shannon said, “We are so honored to partner with Art Garfunkel to share his ...

A roundup of the most newsworthy healthcare press releases from PR Newswire, including Novo Nordisk's affordable semaglutide initiative and the fifth anniversary of COVID-19. NEW YORK, April 4, 2025 ...

A roundup of the most newsworthy healthcare press releases from PR Newswire, including Novo Nordisk's affordable semaglutide initiative and the fifth anniversary of COVID-19. NEW YORK, April 4 ...

Sun Pharma will nab Checkpoint’s anti-PD-L1 antibody cosibelimab, known by its brand name Unloxcyt, and approved by the FDA in December to treat advanced cutaneous squamous cell carcinoma, a type of ...

Lindsay A. Rosenwald, M.D., Fortress' Chairman, President and Chief Executive Officer, said, "The fourth quarter of 2024 was transformational for Fortress, marked by two FDA approvals - Emrosi™ and ...

This transaction is also a successful milestone for Fortress as we expect to receive approximately $28 million at closing in addition to a 2.5% royalty on net sales of UNLOXCYT, and up to an ...